EXOZ EXOZYMES INC.
Nasdaq · SEC CIK 2010788 · EDGAR
- Bought, last 12 months
- $6,405 1 purchases by 1 insiders
- Sold, last 12 months
- $15.4K 1 sales by 1 insiders
- Filings on record
- 19 since 2024-11-18, latest 2026-09-17 17:27
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Korman Tyler Paz | CSO | — | $15.4K |
| Heltzen Michael | CEO | $6,405 | — |
| Perriman Damien Alan | Chief Commercial Off | — | — |
| Opgenorth Paul Hideo | VP, Development | — | — |
| Nawaz Fouad | VP- Fin | — | — |
Transactions 18
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-09-02 19:33 | 2026-08-25+ | EXOZ | Heltzen Michael | CEO | P - Purchase | $7.49 | +855 | 14.0K | +7% | +$6,405 |
| 2026-09-02 19:33 | 2026-08-19 | EXOZ | Heltzen Michael | CEO | A - Grant | $6.40 | +8,841 | 13.9K | +176% | +$56.6K | |
| D | 2026-08-25 19:16 | 2026-08-19 | EXOZ | Perriman Damien Alan | Chief Commercial Off | M - OptEx | — | +19.6K | 28.5K | +221% | — |
| D | 2026-08-25 18:57 | 2026-08-19 | EXOZ | Korman Tyler Paz | CSO | M - OptEx | — | +33.0K | 762.8K | +5% | — |
| M | 2026-04-10 16:30 | 2026-04-08+ | EXOZ | Korman Tyler Paz | CSO | S - Sale | $10.28 | -1,500 | 729.1K | -0.2% | -$15.4K |
| D | 2026-04-08 19:22 | 2026-04-01 | EXOZ | Perriman Damien Alan | Chief Commercial Off | A - Grant | $0.00 | +62.8K | 62.8K | New | $0 |
| 2026-04-08 06:27 | 2026-04-01 | EXOZ | Perriman Damien Alan | Chief Commercial Off | A - Grant | $8.44 | +8,887 | 0 | New | +$75.0K | |
| 2026-04-08 06:23 | 2026-04-01 | EXOZ | Opgenorth Paul Hideo | VP, Development | A - Grant | $8.44 | +3,999 | 645.1K | +0.6% | +$33.8K | |
| 2026-04-08 06:17 | 2026-04-01 | EXOZ | Nawaz Fouad | VP- Fin | A - Grant | $8.44 | +5,999 | 9,488 | +172% | +$50.6K | |
| 2026-04-08 06:14 | 2026-04-01 | EXOZ | Korman Tyler Paz | CSO | A - Grant | $8.44 | +5,332 | 730.6K | +0.7% | +$45.0K | |
| 2025-07-02 | 2025-07-02 | EXOZ | Heltzen Michael | CEO | P - Purchase | $10.22 | +1,040 | 10.6K | +11% | +$10.6K | |
| 2025-06-17 | 2025-06-16 | EXOZ | Korman Tyler Paz | VP, Research | A - Grant | $12.54 | +2,990 | 725.3K | +0.4% | +$37.5K | |
| 2025-06-17 | 2025-06-13 | EXOZ | Nawaz Fouad | VP, Fin | A - Grant | $12.54 | +3,489 | 3,489 | New | +$43.8K | |
| 2025-06-17 | 2025-06-13 | EXOZ | Opgenorth Paul Hideo | VP, Development | A - Grant | $12.54 | +2,990 | 641.1K | +0.5% | +$37.5K | |
| M | 2025-01-21 | 2025-01-16+ | EXOZ | Heltzen Michael | CEO | P - Purchase | $10.78 | +1,888 | 3,872 | +95% | +$20.3K |
| 2024-11-19 | 2024-11-15 | EXOZ | Heltzen Michael | CEO | P - Purchase | $11.10 | +1,984 | 1,984 | New | +$22.0K | |
| 2024-11-18 | 2024-11-08 | EXOZ | Opgenorth Paul Hideo | VP, Development | C - Cnv Deriv | $6.40 | +2,344 | 640.5K | +0.4% | +$15.0K | |
| 2024-11-18 | 2024-11-08 | EXOZ | MDB Capital Holdings, LLC | 10% | C - Cnv Deriv | $6.40 | +122.7K | 3.93M | +3% | +$785.0K |
Purchase Sale Sale after option exercise All abbreviations